Status:

UNKNOWN

Left Atrial Function Analysis for Patients With Persistent Atrial Fibrillation Undergoing Pulmonary Vein Isolation

Lead Sponsor:

Semmelweis University Heart and Vascular Center

Conditions:

Persistent Atrial Fibrillation

Catheter Ablation

Eligibility:

All Genders

18-75 years

Brief Summary

This prospective observational study is designed to describe the factors determining the success of pulmonary vein isolation (PVI) for patients with persistent atrial fibrillation (AF). These factors ...

Eligibility Criteria

Inclusion

  • documented, symptomatic persistent atrial fibrillation (AF)
  • catheter ablation is indicated
  • aged 18-75 years
  • signed Patient Informed Consent Form
  • able and willing to comply with all pre-, post-, and follow-up testing and requirements

Exclusion

  • secondary AF
  • paroxysmal, long-standing persistent or permanent AF
  • ejection fraction \< 30%
  • GFR \<30 ml/min/1.73m2
  • unstable angina pectoris or myocardial infarction within the past 2 months
  • severe heart failure (NYHA IV)
  • severe COPD (GOLD III-IV)
  • previous left atrial catheter ablation
  • previous transthoracic cardiac surgery
  • implanted cardiac device (pacemaker, ICD, CRT, VAD)
  • awaiting cardiac transplantation or other cardiac surgery within the next 12 months
  • any contraindication for pulmonary vein isolation, MRI or anticoagulation
  • coagulopathy
  • active malignancy, left atrial myxoma
  • autoimmune disorder, chronic inflammatory disease
  • acute illness, active systemic infection, sepsis
  • women who are pregnant, breast feeding, or planning to become pregnant in the next 12 months
  • aged under 18 years or above 75 years
  • enrollment in other studies, which exclude participation in other studies
  • patient not willing or not able to sign the informed consent form

Key Trial Info

Start Date :

August 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2019

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03242694

Start Date

August 1 2017

End Date

December 31 2019

Last Update

August 8 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Heart and Vascular Center of Semmelweis University

Budapest, Hungary, 1122